Hashem Taha is a cancer immunologist turned investor and company builder, currently focusing on enterprise AI, bio, healthtech, and computational sciences. They serve as an investor across multiple companies including aiXplain, Vectara, and Recursion while advising institutional investors and family offices on significant pharmaceutical acquisitions. Hashem has launched companies from stealth mode, developed product marketing strategies, and led capital raising efforts totaling over $500 million. They hold a Master’s degree in Biomedical Engineering from the University of Toronto and have completed advanced finance studies at New York University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices